Today (February 9), the Shanghai and Shenzhen stock markets showed a shock rebound pattern as a whole. The three major A-share indexes opened slightly lower in the morning, and then the trend tended to fluctuate throughout the morning. In the afternoon, the three indexes further accelerated their rebound, and the pattern of concussion and upward attack was obvious. Finally, the three indexes closed red across the board, and the Shenzhen Composite Index and gem index performed better.
In this regard, Huaxi Securities Co.Ltd(002926) said that A-Shares deduce the “first developing and then restraining”, and look at the current round of spring market rationally. Since the beginning of the year, the risk appetite of A-share market has continued to weaken under the disturbance of overseas monetary policy tightening expectations and capital pre holiday risk aversion factors. During the Spring Festival, overseas stock markets were in danger, and most of the world’s major stock indexes rose. At the same time, China’s policy level repeatedly called for “steady growth”, and the market sentiment after the festival is expected to be repaired. In addition, the recent public offering to open self purchase and the liberalization of purchase restrictions of popular funds will help the inflow of incremental funds into A-Shares after the festival. A shares are expected to meet the “oversold rebound” in February.
At the same time, Everbright Securities Company Limited(601788) believes that the market still has the power to rebound in the near future. There is no need to remain pessimistic and continue to focus on individual stocks over the index. In terms of strategy, digital currency is expected to continue to strengthen, which can be paid appropriate attention. At the same time, infrastructure is still a hot spot in the short-term direction. In the medium and long term, China is expected to get out of the independent market and actively pay attention to sectors such as medicine, military industry, new energy and mandatory consumption.
sector:
I. concept of traditional Chinese medicine
Xiangcai securities mentioned that taking advantage of the policy, it pays attention to the innovation of traditional Chinese medicine and the leading enterprises of brand traditional Chinese medicine. The biggest positive factor for the traditional Chinese medicine industry in 2022 is policy support. On the demand side, the rigid demand characteristics of the pharmaceutical industry and the upgrading of pharmaceutical consumption jointly support the steady growth of the demand of the traditional Chinese medicine industry. On the policy side, a series of favorable policies have been formed to promote the innovation of traditional Chinese medicine, the development of formula particles, the support of medical insurance and payment policies, and the continuous addition of traditional Chinese medicine decoction pieces can not exceed 25%, bringing policy dividends and new demand to the traditional Chinese Medicine industry. The unique advantage of “preventing disease” brings development opportunities to the traditional Chinese medicine industry. On the performance side, the traditional Chinese medicine industry walked out of the low point and showed a marginal improvement trend. On the valuation side, the traditional Chinese medicine industry still has certain valuation advantages after valuation repair. “Policy + pharmaceutical consumption upgrading + performance improvement + valuation advantages” jointly build investment opportunities in the traditional Chinese medicine industry. It is suggested to pay attention to the areas of policy encouragement and policy haven.
The agency further analyzed: (1) pay attention to the innovation of modern traditional Chinese medicine, and pay attention to the innovation targets of modern traditional Chinese medicine with strong R & D strength and layout of large categories (large market: cardio cerebrovascular + fast growth: pediatric medicine); (2) Pay attention to the advantages of brand traditional Chinese medicine, formula and raw materials, and jointly build a moat of brand traditional Chinese medicine; (3) Benefit from consumption upgrading and pay attention to the subject matter of industrial chain extension and strong brand advantage.
In addition, Sinolink Securities Co.Ltd(600109) said that benefiting from the successive implementation of policies in the traditional Chinese medicine sector, the industry will achieve sustained, healthy and high-quality development. Based on the expectation of price increase superimposed by industrial policies, we suggest paying attention to the investment opportunities in the eight subdivided directions of traditional Chinese medicine: 1) innovative traditional Chinese medicine; 2) Traditional Chinese medicine formula granules; 3)OTC； 4) Brand traditional Chinese medicine; 5) Traditional Chinese medicine; 6) Chinese patent medicine; 7) Traditional Chinese medicine services; 8) Relevant supporting supply chain, etc. It is suggested to pay attention to: Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) , China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) , Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) , Beijing Tongrentang Co.Ltd(600085) , GUSHENG hall, etc.
II. Digital currency
Huaxi Securities Co.Ltd(002926) pointed out that in 2022, we should pay close attention to the main context of digital economy, take data flow as the clue, and explore new technological innovation opportunities such as intelligent sensing, silicon optical transmission and storage to cloud native driven by new applications such as metauniverse, industrial Internet and intelligent driving.
China Merchants Securities Co.Ltd(600999) mentioned that after the promotion of the Winter Olympic Games, the digital RMB will be further familiar to the market, and its industrial chain enterprises and traditional banking industry will benefit from it. On the one hand, digital RMB hardware equipment manufacturers will benefit from the market opportunities brought by digital RMB Hard Wallet, while software developers will benefit from the business growth brought by the upgrading of banking systems outside China. On the other hand, the cross-border application of digital RMB will benefit the traditional banking business through “spillover effect”, with retail payment, foreign currency exchange and cross-border remittance bearing the brunt.
Guosheng Securities said that it is optimistic about the opportunities that the reconstruction of China’s electronic payment industry chain by digital RMB may bring to relevant institutions. Suggestions: 1. Bank acquiring service providers: card transfer, Lakala Payment Co.Ltd(300773) , Newland Digital Technology Co.Ltd(000997) ; 2. Financial IT / banking service providers: Shenzhen Forms Syntron Information Co.Ltd(300468) , Northking Information Technology Co.Ltd(002987) ; 3. Digital RMB related operating institutions: Industrial And Commercial Bank Of China Limited(601398) , Agricultural Bank Of China Limited(601288) , Bank Of China Limited(601988) , China Construction Bank Corporation(601939) , Bank Of Communications Co.Ltd(601328) , Postal Savings Bank Of China Co.Ltd(601658) , China Merchants Bank Co.Ltd(600036) , Alibaba, Tencent, etc; 4. Security chip company: Unigroup Guoxin Microelectronics Co.Ltd(002049) , Huada electronics, etc; 5. Card dealer: Hengbao Co.Ltd(002104) , Chutian Dragon Co.Ltd(003040) , Wuhan Tianyu Information Industry Co.Ltd(300205) etc.
summary of one picture:
